GF Fund Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$55K Hold
484
﹤0.01% 406
2025
Q1
$50.9K Buy
484
+87
+22% +$9.15K ﹤0.01% 418
2024
Q4
$42.5K Buy
+397
New +$42.5K ﹤0.01% 403